OncoQuest's Series A Round

OncoQuest raised a round of funding on November 19, 2015. Investors include Hepalink.

OncoQuest is a privately held, Canadian based pharmaceutical company focused on the development and commercialization of immunotherapies for cancer. OncoQuest's technology platform includes a panel of…

Articles about OncoQuest's Series A Round: